Mednet Logo
HomePrimary Care
Primary Care

Primary Care

Physician perspectives on preventive care, chronic disease management, and evidence-based primary care practice.

Recent Discussions

What is the importance of finding a positive titer for TS-HDS and what treatment would be advised for these patients?

1
2 Answers

Mednet Member
Mednet Member
Neurology · University of Minnesota

TS-HDS antibodies were first described by investigators from Washington University in St. Louis (2003) in five patients with painful sensory axonal neuropathy [1]. Further studies by the same group indicated that TS-HDS antibodies were associated with prominent neuropathic pain in the upper extremit...

What methods have you found successful in getting young children to use nasal sprays?

1 Answers

Mednet Member
Mednet Member
Allergy & Immunology · University of Chicago

Intranasal corticosteroid nasal sprays (INCS) are beneficial in controlling symptoms in children with allergic rhinitis but acceptance is often a barrier to use. I advise parents first start with a gentle nasal saline spray to help their child accept the sensation of liquid in the nose. Parents can ...

Would you add an additional alkali medication for patients with recurrent uric acid nephrolithiasis who are on high doses of potassium citrate and continue to have acidic urine?

1
1 Answers

Mednet Member
Mednet Member
Nephrology · Mayo Clinic

Maybe. My first concern is poor compliance with potassium citrate. I would like to see the patients home pH records. I strongly encourage patients on alkali therapy to test urine pH periodically, and more frequently if a dose adjustment appears to be needed. I prefer potassium citrate to sodium bica...

For patients with kidney stone disease and chronic kidney disease, is there an eGFR threshold at which you no longer recommend pursing 24 hour urine stone risk studies?

2 Answers

Mednet Member
Mednet Member
Nephrology · Medical College of Wisconsin

While I agree with Dr. Erickson's comments in general, though, I have encountered patients that newly presented for stone disease at late stages of CKD and even on dialysis. The critical consideration is whether there is evidence of ongoing stone formation/growth. We must be aware that a stone passa...

How do you approach hematuria in a patient with diabetic nephropathy?

3 Answers

Mednet Member
Mednet Member
Nephrology · Penn Medicine Cherry Hill

This is a difficult question to answer. If young, no risk factors for GU malignancy and only microscopic hematuria would generally not pursue but make patient aware of small risk and make sure PCP also knows. Helpful to know if red cells are dysmorphic and if there is also proteinuria. Gross hematur...

Would you transition from denosumab to anabolic agents in patients who are in urgent need for extensive dental work?

6
2 Answers

Mednet Member
Mednet Member
Endocrinology · Boston University School of Medicine

From my experience, this is a catch-22. If you stop the Denosumab you will markedly increase osteoclastic activity throughout the entire skeleton which is why it is recommended that you not stop the medication without some other intervention. I have had several patients with either osteonecrosis of ...

How do you counsel patients with acute intermittent porphyria when it comes to fasting for religious reasons?

1 Answers

Mednet Member
Mednet Member
Hematology · The Mass General Porphyria Center

This is a very difficult question and it depends on the individual patient, their disease severity, their particular triggers, and how they have done in the past with caloric restriction. The patient may want to speak with a clergy member for guidance in this situation as well. For inst...

Would you recommend a SGLT2i for a non-diabetic patient with recurrent uric acid or calcium phosphate nephrolithiasis?

1
1 Answers

Mednet Member
Mednet Member
Nephrology · Mayo Clinic

No. A major risk factor for uric acid stones is low urine pH. A major risk factor for calcium phosphate (as opposed to calcium oxalate) stones is high urine pH. I am not aware that SGLT2 inhibitors substantially change urine pH. Stephen B. Erickson, MD

Would you recommend dual antiplatelet therapy or anticoagulation for a patient previously on aspirin who has a breakthrough stroke with history of CADASIL?

1
2 Answers

Mednet Member
Mednet Member
Neurology · University of Colorado, Climate & Health Dept

CADASIL is a genetic condition with a presumed mechanism of vascular injury to be disruption of the blood-brain barrier and non-atherosclerotic angiopathy. Thus, it makes sense that no anti-thrombotic has been show to reduce stroke risk. It's expert consensus to do daily aspirin, but this is more to...

What is the optimal antithrombotic management, if at all, in patients with incidentally identified findings of multiple silent embolic appearing cerebral infarcts?

2
3 Answers

Mednet Member
Mednet Member
Neurology · HCA Houston Healthcare

It is important to confirm the pattern is embolic. If unsure, input from a specialized physician (such as vascular neurology or neuro-radiology, if available) can aid in confirming the diagnosis. Various white matter findings may mimic an embolic pattern, and distinguishing between unilateral...